4//SEC Filing
Butt Tausif 4
Accession 0001209191-22-012922
CIK 0001340652other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 8:56 PM ET
Size
8.3 KB
Accession
0001209191-22-012922
Insider Transaction Report
Form 4
Butt Tausif
EVP, Chief Operating Officer
Transactions
- Award
Restricted Stock Units
2022-02-22+41,400→ 41,400 total→ Common Stock (41,400 underlying) - Award
Stock Option (right to buy)
2022-02-22+52,200→ 52,200 totalExercise: $29.83Exp: 2032-02-22→ Common Stock (52,200 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
- [F2]The restricted stock units awarded on February 22, 2022, vests in four equal installments on January 1, 2023, January 1, 2024, January 1, 2025, and January 1, 2026, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.
- [F3]The option was granted on February 22, 2022, and 25% of the total number of shares of common stock subject to the option vests on January 1, 2023, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date.
- [F4]Not applicable.
Documents
Issuer
ChemoCentryx, Inc.
CIK 0001340652
Entity typeother
Related Parties
1- filerCIK 0001845266
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 8:56 PM ET
- Size
- 8.3 KB